Aravind Shivasami

Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.

T. Price, N. Tebbutt, Chee Khoon Lee, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Novel Function for UDP Glycosyltransferase 8: Galactosidation of Bile Acids

Pramod C. Nair, D. Hu, P. Mackenzie, 2015, Molecular Pharmacology.

BRAF V600E Mutation Detection Using High Resolution Probe Melting Analysis

T. Price, N. Tebbutt, J. Hardingham, 2012 .

The Capacity of the Fecal Microbiota From Malawian Infants to Ferment Resistant Starch

G. Young, G. Rogers, C. Christophersen, 2019, Front. Microbiol..

Intestinal Microbiota Composition in Sudden Infant Death Syndrome and Age‐Matched Controls

S. Taylor, G. Rogers, L. Leong, 2017, The Journal of pediatrics.

Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer

D. Cunningham, T. Price, N. Tebbutt, 2014, International journal of cancer.

Microsoft Word-50524961-file00.docx

Pramod C. Nair, P. Mackenzie, R. Meech, 2014 .

Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.

T. Price, N. Tebbutt, C. Murone, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.